mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.4 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |